Analysts are upbeat on the prospects of healthcare services provider Raffles Medical Group for they expect FY2021 ending in December to bring it “some normalisation”.

In its recent results for FY2020, the group reported earnings of $65.9 million, up 9.3% y-o-y thanks to its provision of new services such as the Covid-19 Polymerase Chain Reaction (PCR) and serology testing.

See: Raffles Medical Group posts 9.3% higher FY20 earnings of $65.9 mil thanks to new services such as PCR testing

To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook